title: Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats.
abstract: In a rat model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis (CF), we studied whether the inflammatory response could be altered by intraperitoneal treatment with recombinant rat interferon-gamma (rrIFN-gamma). Rats were treated either before or after intratracheal challenge with P. aeruginosa embedded in alginate beads. Rats treated after challenge had a significant reduction in the severity of macroscopic lung inflammation compared with rats treated before challenge (P = 0.004) and controls (P = 0.003). The histopathology in controls was dominated by numerous polymorphonuclear leucocytes (PMN) (> or = 90%) surrounding the alginate beads like in CF. This could be caused by a Th2-like response. In contrast, a complete shift to a chronic-type inflammation dominated by mononuclear leucocytes (> or = 90% lymphocytes and plasma cells) and granulomas was observed in both rrIFN-gamma-treated groups of rats. This could be caused by a Th1-like response. There was no significant difference in lethality between the groups, and the antibody titres against P. aeruginosa sonicate and alginate were similar in the treated rats and controls. Since the ongoing lung tissue damage in CF patients has been shown to be caused by elastase secreted by PMN, which dominate the P. aeruginosa lung infection, our findings offer a possible new strategy of modifying the inflammatory response in CF patients.
authors.affiliation: Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
authors.forename: H K
authors.initials: HK
authors.lastname: Johansen
authors.forename: H P
authors.initials: HP
authors.lastname: Hougen
authors.forename: J
authors.initials: J
authors.lastname: Rygaard
authors.forename: N
authors.initials: N
authors.lastname: Høiby
mesh_terms: D000818:Animals; D003550:Cystic Fibrosis / Q000276:immunology / Q000473:pathology / Q000628:therapy; D004195:Disease Models, Animal; D005260:Female; D007249:Inflammation / Q000628:therapy*; D007371:Interferon-gamma / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D011552:Pseudomonas Infections / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D051381:Rats; D011917:Rats, Inbred Lew; D011994:Recombinant Proteins; D018417:Th1 Cells / Q000276:immunology
chemical_list: D011994:Recombinant Proteins; D007371:Interferon-gamma